General Electric 7-4292 Clock Radio

this three- dimensional treatment contains a unique combination of ingredients to dramatically improve severe signs of intrinsic aging around the eyes in mature skin. immediately, optical diffusers improve radiance and minimize the appearance of dark circles and capillaries. within four to twelve weeks, a complex of flavonoids and synergistic peptides strengthens blood vessel walls, improves lymphatic drainage, and eliminates hemoglobin's colored end-products to dramatically improve dark circles and puffiness. by twelve weeks and beyond, blueberry extract interrupts the formation of advanced glycation end-products (a.g.e.) and proxylane restores water and nutrient content to the dermal epidermal junction (d.e.j.) to increase skin elasticity and thickness for dramatic improvement of wrinkles and crow's feet. * optical diffusers improve radiance in tired, dull eyes * complex of flavonoids and synergistic peptides reduces the appearance of dark circles and diminishes puffiness and under-eye bags * proxylane re

a.g.e. interrupter is specifically formulated to improve the creping, thinning appearance of mature skin caused by intrinsic or internal aging processes such as glycation. glycation occurs when excess glucose molecules stick to collagen and elastin fibers, eventually binding them together and leading to the formation of advanced glycation end-products (a.g.e.). glycated collagen and elastin fibers lose the ability to function normally, and the body cannot break them down and replace them, which leads to severe wrinkling of the skin. a.g.e. interrupter is a unique treatment formulated with 4% blueberry extract, 30% proxylane(tm), and 0.2% phytosphingosine to help prevent the glycation process and correct severe signs of intrinsic aging in mature skin. * blueberry extract slows down the process of advanced glycation end-product (a.g.e.) formation, preventing the rigidification of collagen and elastin fibers * proxylane(tm) stimulates gag synthesis, restoring water and nutrients to the dermal epidermal junctio